List of publications

All the publications of the C3M teams.

Export in CSV
IL-7 germline variant: setting the stage for immune-related adverse events.

Authors Issaoui H, Ricci JE

Molecular oncology Feb 2023

IRE1α overexpression in malignant cells limits tumor progression by inducing an anti-cancer immune response.

Authors Martinez-Turtos A, Paul R, Grima-Reyes M, Issaoui H, Krug A, Mhaidly R, Bossowski JP, Chiche J, Marchetti S, Verhoeyen E, Chevet E, Ricci JE

Oncoimmunology Sep 2022

Keeping Cell Death Alive: An Introduction into the French Cell Death Research Network.

Authors Ichim G, Gibert B, Adriouch S, Brenner C, Davoust N, Desagher S, Devos D, Dokudovskaya S, Dubrez L, Estaquier J, Gillet G, Guénal I, Juin PP, Kroemer G, Legembre P, Levayer R, Manon S, Mehlen P, Meurette O, Micheau O, Mignotte B, Nguyen-Khac F, Popgeorgiev N, Poyet JL, Priault M, Ricci JE, Riquet FB, Susin SA, Suzanne M, Vacher P, Walter L, Mollereau B

Biomolecules Jul 2022

Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression.

Authors Grima-Reyes M, Vandenberghe A, Nemazanyy I, Meola P, Paul R, Reverso-Meinietti J, Martinez-Turtos A, Nottet N, Chan WK, Lorenzi PL, Marchetti S, Ricci JE, Chiche J

Science advances Jul 2022

Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality.

Authors Krug A, Tari G, Saidane A, Gaulard P, Ricci JE, Lemonnier F, Verhoeyen E

Cancers May 2022

Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity.

Authors Bernard PL, Delconte R, Pastor S, Laletin V, Costa Da Silva C, Goubard A, Josselin E, Castellano R, Krug A, Vernerey J, Devillier R, Olive D, Verhoeyen E, Vivier E, Huntington ND, Nunes J, Guittard G

Journal for immunotherapy of cancer May 2022

An optimized measles virus glycoprotein-pseudotyped lentiviral vector production system to promote efficient transduction of human primary B cells.

Authors Vamva E, Ozog S, Verhoeyen E, James RG, Rawlings DJ, Torbett BE

STAR protocols Mar 2022

Importance of T, NK, CAR T and CAR NK Cell Metabolic Fitness for Effective Anti-Cancer Therapy: A Continuous Learning Process Allowing the Optimization of T, NK and CAR-Based Anti-Cancer Therapies.

Authors Krug A, Martinez-Turtos A, Verhoeyen E

Cancers Jan 2022

Disruption of HIV-1 co-receptors CCR5 and CXCR4 in primary human T cells and hematopoietic stem and progenitor cells using base editing.

Authors Knipping F, Newby GA, Eide CR, McElroy AN, Nielsen SC, Smith K, Fang Y, Cornu TI, Costa C, Gutierrez-Guerrero A, Bingea SP, Feser CJ, Steinbeck B, Hippen KL, Blazar BR, McCaffrey A, Mussolino C, Verhoeyen E, Tolar J, Liu DR, Osborn MJ

Molecular therapy : the journal of the American Society of Gene Therapy Jan 2022

CLEC12B Is a Melanocytic Gene Regulating the Color of the Skin.

Authors Sormani L, Montaudie H, Blot L, Heim M, Cardot Leccia N, Mhaidly R, Verhoeyen E, Regazzetti C, Nottet N, Cheli Y, De Donatis GM, Dabert Gay AS, Debayle D, Taquin Martin H, Gesbert F, Rocchi S, Tulic MK, Passeron T

The Journal of investigative dermatology Dec 2021